1887
Volume 2026, Issue 1
  • ISSN: 1999-7086
  • E-ISSN: 1999-7094

Acquired factor XIII (F) deficiency is a rare and often underdiagnosed bleeding disorder. Because standard coagulation tests typically yield normal results, diagnosis and treatment are often delayed in patients with unexplained hemorrhage.

We report the case of a 56-year-old man who presented with severe, recurrent epistaxis unresponsive to conventional management. Initial coagulation tests—including prothrombin time, international normalized ratio, activated partial thromboplastin time, and fibrinogen levels—were all within normal limits. Despite interventional radiology and surgical measures, bleeding persisted. An F activity assay revealed a mild deficiency (48.7%; reference range: 60–130%). Administration of recombinant F (catridecacog, 10 IU/kg) led to rapid clinical improvement and resolution of bleeding.

This case illustrates the diagnostic challenge posed by acquired F deficiency and underscores the importance of including it in the differential diagnosis of unexplained bleeding, especially when standard coagulation parameters are unremarkable.

Prompt recognition and targeted replacement therapy with recombinant F can be life-saving in acquired F deficiency. F activity testing should be considered early in patients with persistent bleeding of unknown origin.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/jemtac.2026.18
٢٠٢٦-٠٢-٠٤
٢٠٢٦-٠٢-٠٦

القياسات

Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2026/1/jemtac.2026.18.html?itemId=/content/journals/10.5339/jemtac.2026.18&mimeType=html&fmt=ahah

References

  1. Mangla A, Hamad H, Killeen RB, Kumar A. Factor XIII deficiency. StatPearls [Internet]: StatPearls Publishing; 2024.
    [Google الباحث العلمي]
  2. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona É. Factor XIII: A coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011 Jul; 91:(3):931–72. https://doi.org/10.1152/physrev.00016.2010.
    [Google الباحث العلمي]
  3. Kleber C, Sablotzki A, Casu S, Olivieri M, Thoms K-M, Horter J, et al. The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing. Crit Care. 2022 Mar 24 26:(1):69. https://doi.org/10.1186/s13054-022-03940-2
    [Google الباحث العلمي]
  4. Khandelwal V, Sharma SK, Doval D, Kumar M, Choudhary D, Sharma R, et al. Factor XIII deficiency with a novel nonsense mutation. Indian J Hematol Blood Transfus. 2020 Feb22; 36:(3):588–9. https://doi.org/10.1007/s12288-020-01262-3.
    [Google الباحث العلمي]
  5. Golpayegani MV, Behnia H, Araghi MA, Ansari G. Factor XIII deficiency, review of the literature and report of a case. J Compr Ped. 2016 Nov; 7:(4):e30303. https://doi.org/10.17795/compreped-30303
    [Google الباحث العلمي]
  6. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost. 2009; 35:(4):426–38. https://doi.org/10.1055/s-0029-1225765
    [Google الباحث العلمي]
  7. Dorgalaleh A, Jozdani S, Zadeh MK. Factor XIII deficiency: Laboratory, molecular, and clinical aspects. Semin Thromb Hemost. 2025 Mar; 51:(2):155–69. https://doi.org/10.1055/s-0044-1796673
    [Google الباحث العلمي]
  8. Levy JH, Greenberg C. Biology of factor XIII and clinical manifestations of factor XIII deficiency. Transfusion. 2013 May; 53:(5):1120–31. https://doi.org/10.1111/j.1537-2995.2012.03865.x
    [Google الباحث العلمي]
  9. Duranteau O, Tatar G, Demulder A, Tuna T. Acquired factor XIII deficiency: A scoping review. Eur J Anaesthesiol Intensive Care. 2023 Sep 29; 2:(5):e0035. https://doi.org/10.1097/EA9.0000000000000035
    [Google الباحث العلمي]
  10. Hayat M, Ariëns RAS, Moayyedi P, Grant PJ, O’Mahony S. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002 Mar; 14:(3):249–56. https://doi.org/10.1097/00042737-200203000-00008
    [Google الباحث العلمي]
  11. Ozaki S, Mizuguchi M, Okamoto Y, Yagi H, Kagawa K, Shibata H, et al. Frequent bleeding symptoms associated with autoimmune acquired factor XIII/13 deficiency due to anti-factor XIII A and B subunit antibodies. Am J Hematol. 2022 Nov; 97:(11):1497–500. https://doi.org/10.1002/ajh.26685
    [Google الباحث العلمي]
  12. Legido-Quigley H, Asgari N, Teo YY, Leung GM, Oshitani H, Fukuda K, et al. Are high-performing health systems resilient against the COVID-19 epidemic? Lancet. 2020 Mar14; 395:(10227):848–50. https://doi.org/10.1016/S0140-6736(20)30551-1
    [Google الباحث العلمي]
  13. Sigal A, Bakumenko M, editors. The level of the country’s health care as an indicator of its economic development. International scientific conference “Far East Con” (ISCFEC 2020). Atlantis Press; 2020.
    [Google الباحث العلمي]
  14. Ingerslev J. Laboratory assays in hemophilia. In: ILee CA, Berntorp EE, Hoots WK, Aledort LM, editors. Textbook of hemophilia. Blackwell Publishing Ltd; 2005. p. 235–41.
    [Google الباحث العلمي]
  15. Wilmer M, Rudin K, Kolde H-J, Poetzsch B, Lenz W, Moessmer G, et al. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Thromb Res. 2001 Apr1; 102:(1):81–91. https://doi.org/10.1016/s0049-3848(01)00224-9
    [Google الباحث العلمي]
  16. Katona É, Pénzes K, Molnár É, Muszbek L. Measurement of factor XIII activity in plasma. Clin Chem Lab Med. 2012 Feb 23; 50:(7):1191–202. https://doi.org/10.1515/cclm-2011-0730
    [Google الباحث العلمي]
  17. Duque P, Korte W. Factor XIII in the acute care setting and its relevance in obstetric bleeding. Transfus Med Hemother. 2022 Nov 24; 50:(1):10–7. https://doi.org/10.1159/000526489
    [Google الباحث العلمي]
  18. Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol. 2012 Apr; 95:(4):362–70. https://doi.org/10.1007/s12185-012-1064-3
    [Google الباحث العلمي]
  19. Luo YY, Zhang GS. Acquired factor XIII inhibitor: Clinical features, treatment, fibrin structure and epitope determination. Haemophilia. 2011 May; 17:(3):393–8. https://doi.org/10.1111/j.1365-2516.2010.02459.x
    [Google الباحث العلمي]
  20. Rabik CA, Atkinson MA, Sule S, Strouse JJ. Treatment of an acquired factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure. Transfusion. 2017 Sep; 57:(9):2159–63. https://doi.org/10.1111/trf.14185
    [Google الباحث العلمي]
  21. Kun M, Szuber N, Katona É, Pénzes K, Bonnefoy A, Bécsi B, et al. Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies. Haemophilia. 2017 Jul; 23:(4):590–7. https://doi.org/10.1111/hae.13205
    [Google الباحث العلمي]
  22. Omoto R, Umemura Y, Watanabe A, Nakamoto N, Fujimi S. Factor XIII deficiency with repeated severe postoperative bleeding after laparotomy: A case report. Cureus. 2024 May 17; 16:(5):e60489. https://doi.org/10.7759/cureus.60489
    [Google الباحث العلمي]
  23. Yamanishi S, Kimura H, Hayashi H, Yamaguchi Y, Fujita Y, Nakai T, et al. Acute occlusion of the ventriculoperitoneal shunt due to factor XIII deficiency-related postoperative hemorrhage: A case report. NMC Case Rep J. 2021 Aug 26; 8:(1):573–7. https://doi.org/10.2176/nmccrj.cr.2020-0330
    [Google الباحث العلمي]
  24. Dragu A, Bach AD, Leffler M, Unglaub F, Horch RE. Acute and diffuse postoperative bleeding after free latissimus dorsi flap – Factor XIII deficiency: A case report and review of the literature. Med Sci Monit. 2009 Jan; 15:(1):CS1–4. Available from: https://pubmed.ncbi.nlm.nih.gov/19114970/
    [Google الباحث العلمي]
  25. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, et al. Decreased factor XIII availability for hrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg. 2004 Nov; 99:(5):1564–9. https://doi.org/10.1213/01.ANE.0000134800.46276.21
    [Google الباحث العلمي]
  26. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000 Sep; 54:(3):260–4.https://doi.org/10.1016/s0090-3019(00)00308-6
    [Google الباحث العلمي]
  27. Noitz M, Brooks R, Szasz J, Jenner D, Böck C, Krenner N, et al. Acquired factor XIII deficiency is common during ECMO therapy and associated with major bleeding events and transfusion requirements. J Clin Med. 2023 Jun 18; 12:(12):4115. https://doi.org/10.3390/jcm12124115.
    [Google الباحث العلمي]
  28. Sottilotta G, Luise F, Oriana V, Piromalli A, Santacroce R, Di Lelio A. Use of Catridecacog in a patient with severe factor XIII deficiency undergoing surgery. Hematol Rep. 2019 Feb 19; 11:(1):7912. https://doi.org/10.4081/hr.2019.7912
    [Google الباحث العلمي]
/content/journals/10.5339/jemtac.2026.18
Loading
/content/journals/10.5339/jemtac.2026.18
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Case Report
الموضوعات الرئيسية blood coagulation disorderscase reportfactor XIIIhemorrhage and Italy

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error